Report overview
The global 3D Printing Pharmaceuticals market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is Forecast to Reach $ Million.
FDM Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of 3D Printing Pharmaceuticals include Triastek,Inc., Aprecia, AstraZeneca, FabRx, Multiply Labs, DiHeSys, Merck, Merck KGaA and TNO, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
3D printing pharmaceuticals can be applied to the field of solid preparations, which are dominated by small molecule drugs. Compared with traditional solid preparations, 3D printing pharmaceuticals can better control drug release, improve drug efficacy, reduce drug side effects, and reduce dosing frequency.
This report aims to provide a comprehensive presentation of the global market for 3D Printing Pharmaceuticals, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding 3D Printing Pharmaceuticals. This report contains market size and forecasts of 3D Printing Pharmaceuticals in global, including the following market information:
Global 3D Printing Pharmaceuticals Market Revenue, 2019-2024, 2025-2030, ($ millions)
Global 3D Printing Pharmaceuticals Market Sales, 2019-2024, 2025-2030, (K Units)
Global top five 3D Printing Pharmaceuticals companies in 2023 (%)
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the 3D Printing Pharmaceuticals manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global 3D Printing Pharmaceuticals Market, by Type, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global 3D Printing Pharmaceuticals Market Segment Percentages, by Type, 2023 (%)
FDM
SLS
PB
SLA
SSE
DPE
DOD
MDD
MED
Global 3D Printing Pharmaceuticals Market, by Application, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global 3D Printing Pharmaceuticals Market Segment Percentages, by Application, 2023 (%)
Personalized Pharmacy
Nutrients
Global 3D Printing Pharmaceuticals Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global 3D Printing Pharmaceuticals Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies 3D Printing Pharmaceuticals revenues in global market, 2019-2024 (Estimated), ($ millions)
Key companies 3D Printing Pharmaceuticals revenues share in global market, 2023 (%)
Key companies 3D Printing Pharmaceuticals sales in global market, 2019-2024 (Estimated), (K Units)
Key companies 3D Printing Pharmaceuticals sales share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
Triastek,Inc.
Aprecia
AstraZeneca
FabRx
Multiply Labs
DiHeSys
Merck
Merck KGaA
TNO
Therics
Outline of Major Chapters:
Chapter 1: Introduces the definition of 3D Printing Pharmaceuticals, market overview.
Chapter 2: Global 3D Printing Pharmaceuticals market size in revenue and volume.
Chapter 3: Detailed analysis of 3D Printing Pharmaceuticals manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of 3D Printing Pharmaceuticals in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global 3D Printing Pharmaceuticals capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
